Affiliation:
1. Mark Greener is a freelance medical writer and journalist
Abstract
People with schizophrenia often experience considerable difficulties in daily life because of a wide constellation of symptoms associated with the condition. This article examines the pharmaceutical targets that are being investigated to provide greater efficacy and tolerability than the current dopamine‐focussed drugs.